Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity (Q53304621)
Jump to navigation
Jump to search
scientific article published on August 24, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity |
scientific article published on August 24, 2010 |
Statements
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity (English)
1 reference
Cheolwon Suh
Seok Jin Kim
Kihyun Kim
Yong Park
Byung Soo Kim
Jooryung Huh
Young Hae Ko
Keunchil Park
Won Seog Kim
24 August 2010
1 reference
1 reference
30
1
368-375
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference